USD 34.190.00270.0079%

The entity has beta of -0.1925 which indicates as returns on market increase, returns on owning Virtus LifeSci are expected to decrease at a much smaller rate. During bear market, Virtus LifeSci is likely to outperform the market.. Although it is extremely important to respect Virtus LifeSci Biotech current price movements, it is better to be realistic regarding the information on equity historical returns. The philosophy towards measuring future performance of any etf is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By inspecting Virtus LifeSci Biotechtechnical indicators you can presently evaluate if the expected return of 0.2004% will be sustainable into the future.

Virtus LifeSci Biotech Relative Risk vs. Return Landscape

If you would invest 3,291 in Virtus LifeSci Biotech Clinical Trls ETF on February 17, 2018 and sell it today you would earn a total of 128.27 from holding Virtus LifeSci Biotech Clinical Trls ETF or generate 3.9% return on investment over 30 days. Virtus LifeSci Biotech Clinical Trls ETF is generating 0.2004% of daily returns assuming volatility of 1.385% on return distribution over 30 days investment horizon. In other words, 12% of equities are less volatile than the company and above 97% of equities are expected to generate higher returns over the next 30 days.

Daily Expected Return (%)

Risk (%)

Considering 30-days investment horizon, Virtus LifeSci Biotech Clinical Trls ETF is expected to generate 1.48 times more return on investment than the market. However, the company is 1.48 times more volatile than its market benchmark. It trades about 0.14 of its potential returns per unit of risk. The DOW is currently generating roughly 0.0 per unit of risk.

Virtus LifeSci Daily Price Distribution

The median price of Virtus LifeSci for the period between Sat, Feb 17, 2018 and Mon, Mar 19, 2018 is 34.1927 with a coefficient of variation of 2.79. The daily time series for the period is distributed with a sample standard deviation of 0.95, arithmetic mean of 34.08, and mean deviation of 0.81. The Etf did not receive any noticable media coverage during the period.

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Virtus LifeSci Biotech Clinical Trls ETF are ranked lower than 9 (%) of all global equities and portfolios over the last 30 days.

One Month Efficiency

Virtus LifeSci Sharpe Ratio = 0.1447

Best

Portfolio

Best

Equity

Good Returns

Average Returns

Small Returns

BBC

Cash

Small

Risk

Average

Risk

High

Risk

Huge

Risk

Negative Returns

Estimated Market Risk

1.39

actual daily

88 %

of total potential

Expected Return

0.2

actual daily

3 %

of total potential

Risk-Adjusted Return

0.14

actual daily

9 %

of total potential

Based on monthly moving average Virtus LifeSci is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virtus LifeSci by adding it to a well-diversified portfolio.